Abstract:The aim of the present investigation is to identify effective anti-HIV drugs through the in-silico virtual screening of the coumarin pharmacophore with or without substituents. Virtual screening started with target identification through computation docking and interactions, binding affinity through molecular dynamics, and the ADMET profile through the use of various enzymes. The target study suggests that the target is involved in various stages of HIV replication and in determining the ways in which non-nucleoside reverse transcriptase inhibitors (RTIs) influence it. The interaction pattern and simulation study conclude the specific affinity of coumarin pharmacophore to the HIV's reverse transcriptase enzyme, especially 3HVT. Moreover, the amide linkage worked as a synergistic bridge to provide more interaction to the pharmacophore. The initial results led to the determination of 83 virtual amide-like molecules, which were screened through docking and MD studies (100 ns) on the best-suited enzyme HIV's reverse transcriptase enzyme, such as PDB ID "3HVT". The virtual screening study revealed the high affinity of compounds 7d and 7e with the lowest IC50 values of 0.729 and 0.658 μM; moreover, their metabolism pattern study, toxicity, and QED values in a range of 0.31-0.40 support a good drug candidate. The two compounds were also synthesized and characterized for future in vitro and in vivo studies. The in silico-based descriptor of compounds 7d and 7e indicates the potential future and provides the best two molecules and their synthetic route for the development of a more effective drug to combat HIV/AIDS epidemics.

Coumarin-based derivatives with potential anti-HIV activity

Recent advances in natural anti‐HIV triterpenoids and analogs

Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease

Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities

[Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs].

Recent Developments of Coumarin-based Hybrids in Drug Discovery

Coumarin: An emerging antiviral agent

New developments in natural products-based anti-AIDS research

Discovery, Optimization, and Target Identification of Novel Coumarin Derivatives As HIV-1 Reverse Transcriptase-Associated Ribonuclease H Inhibitors.

Structure and Anti-HIV Activity of Betulinic Acid Analogues

Pharmacological and Nutritional Effects of Natural Coumarins and Their Structure–Activity Relationships

Pharmacological And Nutritional Effects Of Natural Coumarins And Their Structure-Activity Relationships

Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase

Synthesis and HIV-1 reverse transcriptase inhibitory activity of 3,4-disubstituted coumarin derivatives

Rational Design and Structure-Activity Relationship of Coumarin Derivatives Effective on HIV-1 Protease and Partially on HIV-1 Reverse Transcriptase.

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV

Advances on Biological Activities of Coumarins

A Step Towards Optimization of Amide-Linked Coumarin Pharmacophore: As an Anti-HIV Agent

Advances in Research on Betulinic Acid Derivatives as Anti-HIV Agents

Advances in Pharmacology and Toxicology of Coumarins

Coumarin Derivatives with Anticancer Activities: an Update.